CIK 0000863894
- Non-accelerated filer
- Smaller reporting company
VERU INC.
Sign in to watch- Ticker
- VERU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- WI
- Entity type
- Operating
- EIN
- 391144397
- Phone
- +1 312-595-9123
- Business address
- 2916 N. MIAMI AVENUE, SUITE 1000, MIAMI, FL, 33127
- Former names
- FEMALE HEALTH CO
- 4 Open-market buy Director bought 3,000 shares at $1.47 ($4,410)
- 4 Open-market buy Director bought 3,500 shares at $1.47 ($5,145)
- 4 Open-market buy Director bought 3,000 shares at $1.43 ($4,290)
- 4 Open-market buy Director bought 3,500 shares at $1.47 ($5,145)
- 4 Open-market sale President and CEO sold 4,996 shares at $1.50 ($7,494)
- 4 Open-market buy Director bought 3,400 shares at $1.39 ($4,726)
- 4 Open-market buy Director bought 5,000 shares at $1.27 ($6,350)
- 4 Open-market buy Director bought 3,000 shares at $1.32 ($3,960)
- 4 Open-market buy Director bought 6,000 shares at $1.30 ($7,800)
- 4 Open-market buy Director bought 5,000 shares at $1.35 ($6,750)
- 4 Open-market buy Director bought 5,000 shares at $1.36 ($6,795)
- 4 Open-market sale President and CEO sold 4,650 shares at $1.52 ($7,085)
- 4 Open-market buy Director bought 13,681 shares at $1.36 ($18,654)
- 4 Open-market sale President and CEO sold 10,455 shares at an average $1.50 ($15,724)
- 4 Open-market sale President and CEO sold 4,400 shares at $1.33 ($5,859)
- 4 Open-market sale President and CEO sold 25,600 shares at an average $1.34 ($34,347)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 30,000 shares at $1.42 ($42,672)
- 4 Open-market buy Chief Scientific Officer bought 100,000 shares at an average $1.46 ($146,160)
Page 8 of 30 · 594 filings